Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, Dongchuan Road 800, Shanghai 200240, China.
Mol Aspects Med. 2013 Feb;34(1):39-58. doi: 10.1016/j.mam.2012.11.001. Epub 2012 Nov 16.
The human gut is densely populated by commensal and symbiotic microbes (the "gut microbiota"), with the majority of the constituent microorganisms being bacteria. Accumulating evidence indicates that the gut microbiota plays a significant role in the development of obesity, obesity-associated inflammation and insulin resistance. In this review we discuss molecular and cell biological mechanisms by which the microbiota participate in host functions that impact the development and maintenance of the obese state, including host ingestive behavior, energy harvest, energy expenditure and fat storage. We additionally explore the diverse signaling pathways that regulate gut permeability and bacterial translocation to the host and how these are altered in the obese state to promote the systemic inflammation ("metabolic endotoxemia") that is a hallmark of obesity and its complications. Fundamental to our discussions is the concept of "crosstalk", i.e., the biochemical exchange between host and microbiota that maintains the metabolic health of the superorganism and whose dysregulation is a hallmark of the obese state. Differences in community composition, functional genes and metabolic activities of the gut microbiota appear to distinguish lean vs obese individuals, suggesting that gut 'dysbiosis' contributes to the development of obesity and/or its complications. The current challenge is to determine the relative importance of obesity-associated compositional and functional changes in the microbiota and to identify the relevant taxa and functional gene modules that promote leanness and metabolic health. As diet appears to play a predominant role in shaping the microbiota and promoting obesity-associated dysbiosis, parallel initiatives are required to elucidate dietary patterns and diet components (e.g., prebiotics, probiotics) that promote healthy gut microbiota. How the microbiota promotes human health and disease is a rich area of investigation that is likely to generate fundamental discoveries in energy metabolism, molecular endocrinology and immunobiology and may lead to new strategies for prevention of obesity and its complications.
人体肠道中密集分布着共生和共生微生物(“肠道微生物群”),其中大多数组成微生物是细菌。越来越多的证据表明,肠道微生物群在肥胖症、肥胖相关炎症和胰岛素抵抗的发展中起着重要作用。在这篇综述中,我们讨论了微生物群参与影响肥胖状态的发展和维持的宿主功能的分子和细胞生物学机制,包括宿主摄食行为、能量获取、能量消耗和脂肪储存。我们还探讨了调节肠道通透性和细菌易位到宿主的不同信号通路,以及这些通路在肥胖状态下如何改变,以促进全身性炎症(“代谢性内毒素血症”),这是肥胖及其并发症的标志。我们讨论的基本概念是“串扰”,即宿主和微生物群之间的生化交换,这种交换维持着超级生物体的代谢健康,其失调是肥胖状态的标志。肠道微生物群的群落组成、功能基因和代谢活性的差异似乎可以区分瘦人和肥胖者,这表明肠道“生态失调”有助于肥胖的发展和/或其并发症。目前的挑战是确定肠道微生物群中与肥胖相关的组成和功能变化的相对重要性,并确定促进瘦体和代谢健康的相关分类群和功能基因模块。由于饮食似乎在塑造微生物群和促进肥胖相关的生态失调方面起着主导作用,因此需要并行的举措来阐明促进健康肠道微生物群的饮食模式和饮食成分(例如,益生元、益生菌)。微生物群如何促进人类健康和疾病是一个富有研究价值的领域,可能会在能量代谢、分子内分泌学和免疫生物学方面产生基础性发现,并可能为预防肥胖及其并发症提供新的策略。